Saturday, September 19th | 1 Tishri 5781

Subscribe
June 7, 2019 10:24 am

FDA Clears New ReWalk Product for Stroke Survivors

avatar by JNS.org

ReWalk Robotics Ltd.’s ReStore, an exoskeleton for stroke survivors. Photo: Screenshot.

JNS.org – The Food and Drug Administration has cleared a new product geared to help stroke survivors walk again.

Israel-based ReWalk Robotics Ltd. announced on Tuesday that its ReStore product will have a starting price in the United States of $28,900, though leasing options will be available.

Last week, ReStore received the CE mark, allowing it to be sold in the European Union.

ReWalk Robotics Ltd. is known for its exoskeleton that enables paraplegics to walk again. It received FDA clearance in 2014.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.